Skip to main content
icon for Measles cases in U.S. by June 30?

Measles cases in U.S. by June 30?

icon for Measles cases in U.S. by June 30?

Measles cases in U.S. by June 30?

Ended: Jun 30

Jul 31

Dec 31

Ended: Jun 30

Jul 31

Dec 31

$97,924 Vol.

Jun 30, 2026
Polymarket

$97,924 Vol.

Polymarket

2140

$8,187 Vol.

No

2150

$36,434 Vol.

No

2200

$28,875 Vol.

No

2300

$10,871 Vol.

No

2400

$13,559 Vol.

No

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in under-vaccinated communities continues to drive U.S. case counts, with the CDC reporting 2,073 confirmed cases as of June 11, 2026—already approaching the full-year 2025 total of 2,288. Ninety-three percent of 2026 cases link to 30 outbreaks, predominantly among individuals unvaccinated or with unknown MMR status, reflecting sustained endemic circulation after the Americas lost elimination status in late 2025. Recent weekly additions of 40–60 cases underscore active chains in multiple states, though public health containment and seasonal patterns may moderate further growth before June 30. CDC’s weekly surveillance updates, including any new outbreak declarations or revised counts, represent the key near-term data releases that could shift trader-implied probabilities on final June totals.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$97,924
End Date
Jun 30, 2026
Market Opened
Jun 23, 2026, 2:11 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Outcome proposed: No

No dispute

Final outcome: No

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in under-vaccinated communities continues to drive U.S. case counts, with the CDC reporting 2,073 confirmed cases as of June 11, 2026—already approaching the full-year 2025 total of 2,288. Ninety-three percent of 2026 cases link to 30 outbreaks, predominantly among individuals unvaccinated or with unknown MMR status, reflecting sustained endemic circulation after the Americas lost elimination status in late 2025. Recent weekly additions of 40–60 cases underscore active chains in multiple states, though public health containment and seasonal patterns may moderate further growth before June 30. CDC’s weekly surveillance updates, including any new outbreak declarations or revised counts, represent the key near-term data releases that could shift trader-implied probabilities on final June totals.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$97,924
End Date
Jun 30, 2026
Market Opened
Jun 23, 2026, 2:11 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Outcome proposed: No

No dispute

Final outcome: No

Related

icon for Will there be at least 2300 measles cases in the U.S. by July 31, 2026?

Will there be at least 2300 measles cases in the U.S. by July 31, 2026?

85%
icon for Will there be at least 3000 measles cases in the U.S. in 2026?

Will there be at least 3000 measles cases in the U.S. in 2026?

87%
icon for Will there be at least 1800 cyclosporiasis cases in the U.S. by July 31, 2026?

Will there be at least 1800 cyclosporiasis cases in the U.S. by July 31, 2026?

96%

Beware of external links.

Frequently Asked Questions

"Measles cases in U.S. by June 30?" is a prediction market on Polymarket with 5 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "2140" at 0%, followed by "2150" at 0%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 0¢ implies that the market collectively assigns a 0% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Measles cases in U.S. by June 30?" has generated $97.9K in total trading volume since the market launched on May 26, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Measles cases in U.S. by June 30?," browse the 5 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

This is a wide-open market. The current leader for "Measles cases in U.S. by June 30?" is "2140" at just 0%, with "2150" close behind at 0%. With no outcome commanding a strong majority, traders see this as highly uncertain, which can present unique trading opportunities. These odds update in real-time, so bookmark this page to watch how the probabilities evolve.

The resolution rules for "Measles cases in U.S. by June 30?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.